ArticleUpdates in surgery2025

Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial.

Chen Chang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.